Short answer · Medically reviewed summary · Last updated: 2026-04-07
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) is a rare, acquired autoimmune disorder of the peripheral nervous system characterized by progressive weakness and sensory impairment. It occurs when the body’s immune system mistakenly attacks the protective covering of the nerves, known as the myelin sheath, leading to impaired nerve signaling throughout the body. What exactly is Chronic Inflammatory Demyelinating Polyneuropathy? Chronic Inflammatory Demyelinating Polyneuropathy is a neurological condition that primarily affects the peripheral nerves—the nerves located outside the brain and spinal cord.
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) is a rare, acquired autoimmune disorder of the peripheral nervous system characterized by progressive weakness and sensory impairment. It occurs when the body’s immune system mistakenly attacks the protective covering of the nerves, known as the myelin sheath, leading to impaired nerve signaling throughout the body.
Chronic Inflammatory Demyelinating Polyneuropathy is a neurological condition that primarily affects the peripheral nerves—the nerves located outside the brain and spinal cord. Because these nerves are responsible for sending signals to muscles and relaying sensory information back to the brain, damage to the myelin sheath results in weakness, numbness, and tingling. Unlike acute conditions like Guillain-Barré syndrome, Chronic Inflammatory Demyelinating Polyneuropathy follows a chronic or relapsing course, meaning symptoms persist for at least eight weeks or continue to recur over a long period.
While often considered rare, the exact prevalence of Chronic Inflammatory Demyelinating Polyneuropathy is difficult to pinpoint due to diagnostic challenges. Current estimates suggest a prevalence of approximately 1 to 9 per 100,000 individuals worldwide. The condition can affect anyone at any age, though it is most commonly diagnosed in adults, with a slight predominance in males compared to females. At DiseaseMaps.org, 71 people with Chronic Inflammatory Demyelinating Polyneuropathy have joined our community, reflecting the shared journey of those navigating this complex diagnosis.
The symptoms of Chronic Inflammatory Demyelinating Polyneuropathy can vary significantly between patients, but they generally involve a combination of motor and sensory deficits. Key clinical indicators include:
The defining characteristic of Chronic Inflammatory Demyelinating Polyneuropathy is the "demyelinating" aspect, which refers to the loss of the fatty insulation around nerve fibers. This distinguishes it from "axonal" neuropathies, where the nerve fiber itself is damaged. Clinicians often differentiate this condition from similar disorders by using nerve conduction studies, which show slowed nerve impulse transmission, and by analyzing cerebrospinal fluid for elevated protein levels without a corresponding increase in white blood cells.
Medical Disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.